This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
A$184.14
Share price
0.00%
Change (1 day)
30.30%
Change (1 year)
Categories
Market capitalization of Heska Corporation (HSKA)
Last known market cap: A$2.00 Billion
On August 15, 2023 Heska Corporation had a market cap of A$2.00 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Heska Corporation from 2001 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | A$1.92 B | 94.38% |
| 2022 | A$0.98 B | -63.32% |
| 2021 | A$2.69 B | 50.2% |
| 2020 | A$1.79 B | 66.19% |
| 2019 | A$1.08 B | 15.13% |
| 2018 | A$0.93 B | 26.05% |
| 2017 | A$0.74 B | 8.62% |
| 2016 | A$0.68 B | 94.78% |
| 2015 | A$0.35 B | 150.38% |
| 2014 | A$0.14 B | 145.84% |
| 2013 | A$57.14 M | 36.48% |
| 2012 | A$41.87 M | 12.26% |
| 2011 | A$37.3 M | 46.03% |
| 2010 | A$25.54 M | -16.6% |
| 2009 | A$30.62 M | 66.74% |
| 2008 | A$18.36 M | -82.94% |
| 2007 | A$0.10 B | -0.46% |
| 2006 | A$0.10 B | 21.55% |
| 2005 | A$89 M | 19.42% |
| 2004 | A$74.53 M | -50.65% |
| 2003 | A$0.15 B | 408.49% |
| 2002 | A$29.69 M | -68.32% |
| 2001 | A$93.74 M |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | A$70.72 B | 3,419.34% | 🇺🇸 USA |
 Eli Lilly LLY | A$1.051 T | 52,202.65% | 🇺🇸 USA |
 Petco WOOF | A$1.37 B | -31.40% | 🇺🇸 USA |
 Pfizer PFE | A$212.01 B | 10,449.79% | 🇺🇸 USA |
 Merck MRK | A$318.40 B | 15,744.14% | 🇺🇸 USA |
 Novartis NVS | A$351.69 B | 17,400.65% | 🇨🇭 Switzerland |
 Zoetis ZTS | A$103.17 B | 5,033.90% | 🇺🇸 USA |